EN DE
Watch Hygieia Group Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Hygieia Group Limited (1650) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Hygieia Group Limited stock HK$0.14, price HK$0.21, that is 33.3% below the price, quality 77 out of 100. Rating: overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials HK · Based in Singapore · ISIN KYG4677R1074

HG Hygieia Group Limited logo Thin data Nov 14, 2026

Hygieia Group Limited

1650 · HK

Expensive (fair value 33% below the price), but strong company and rising price: meets 2 of 3 rules.

Get notified free when this changes
Quality 77/100 
Rising price (uptrend) 
Low debt 
Thin margins · 2.2% net margin (TTM) 
Mixed vs. peers (6/14) 
Profit last quarter 41% below a year ago. 
Changed on Nov 14: HK$0.1700 → HK$0.1400 
Fair value HK$0.1400 · Overvalued 
Weak Growth (revenue 5y +1.8 %/yr in SGD) 
Negative free cash flow over the last twelve months 
5.8% dividend yield · Pays more than it earns
Narrow moat 33/100 · thin data
Thin data 
Watch Hygieia Group Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$0.2100 HK$0.0360 Fair Value HK$0.1400 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

60‑month range HK$0.0360 – HK$0.2100 · fair‑value band HK$0.1200 – HK$0.1900 · the HK$0.2100 price screens above the HK$0.1400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow Hygieia Group in your weekly email

Every Wednesday you see whether Hygieia Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Hygieia Group Limited, an investment holding company, engages in the provision of general cleaning services in Singapore and Thailand.

Show moreShow less

The company provides general cleaning works for various public and private venues, including shopping malls, commercial and industrial buildings, schools, hotels, and private condominiums, as well as public access areas in town council, public access areas in town councils, a sports stadium, medical centers, commercial buildings, and schools; and for private customers at private residences, offices, retail outlets, and industrial buildings.

It is also involved in the collection of waste and recycling of metal waste and scraps. The company was founded in 1991 and is headquartered in Singapore. Hygieia Group Limited is a subsidiary of TEK Assets Management Limited.

Stock analysis

Hygieia Group Limited (1650) currently trades at HK$0.2100, while our model-based Fair Value estimate is HK$0.1400, 33% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of HK$0.1550 per share, and 1 of the 25 models we run sit above the HK$0.2100 price.

Bear case: the Asset-Based group reads lowest at HK$0.0700, and 24 of the 25 models stay below the price. Data coverage for this calculation is low.

Scenario range: HK$0.1200 (bear) to HK$0.1900 (bull), the price of HK$0.2100 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 77/100 (high quality), in the Industrials sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

Hygieia Group Limited reported revenue of 79.5M SGD in FY2025 versus 71.6M SGD in FY2021, a compound +2.7%/yr. Reported net income was 2.6M SGD in FY2025, compounding −15.5%/yr from FY2021.

Key figures

Market cap HK$420M (≈ $53.5M) Micro · P/E ratio 20.3 · P/S ratio 0.67 · Dividend yield 5.8% · Net margin 3.3% · Return on equity 6.8% · Return on assets (EBIT) 4.4% (5-year average) · Operating margin 0.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 33 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 155% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at −33%, 1650 screens richer than that median.

Fair Value models

Bear HK$0.1200 Fair Value HK$0.1400 Bull HK$0.1900
Price HK$0.2100 · Downside -33.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF HK$0.1200 HK$0.1500 HK$0.1800 82
Growth DCF HK$0.1200 HK$0.1400 HK$0.1700 80
Owner Earnings HK$0.1100 HK$0.1300 HK$0.1700 78
All 25 models by family
DCF Models
FCF DCF HK$0.1200 HK$0.1500 HK$0.1800 82
Owner Earnings HK$0.1100 HK$0.1300 HK$0.1700 78
5Y Revenue Exit HK$0.1100 HK$0.1500 HK$0.2000 73
5Y EBITDA Exit HK$0.1400 HK$0.2100 HK$0.2800 76
5Y P/E Exit HK$0.1300 HK$0.1800 HK$0.2400 71
10Y Revenue Exit HK$0.1100 HK$0.1400 HK$0.1800 68
10Y EBITDA Exit HK$0.1300 HK$0.1800 HK$0.2300 69
10Y P/E Exit HK$0.1200 HK$0.1600 HK$0.2100 65
Earnings-Based
Graham-Dodd HK$0.0500 HK$0.1300 HK$0.1700 65
PEG = 1.0 HK$0.0700 HK$0.1000 HK$0.1300 57
EPV HK$0.0800 HK$0.0900 HK$0.0900 74
Dividend Discount
Gordon GGM HK$0.0900 HK$0.1400 HK$0.1900 68
DDM Multi-Stage HK$0.0900 HK$0.1200 HK$0.1500 67
Multiples
P/E Multiple HK$0.1300 HK$0.1700 HK$0.2100 63
P/S Multiple HK$0.1000 HK$0.1400 HK$0.1700 58
P/B Multiple HK$0.0500 HK$0.0600 HK$0.0800 55
EV/EBIT HK$0.1400 HK$0.1800 HK$0.2200 66
EV/EBITDA HK$0.1800 HK$0.2300 HK$0.2800 67
EV/Revenue HK$0.1100 HK$0.1400 HK$0.1800 54
Asset-Based
NCAV (Graham) HK$0.0500 HK$0.0700 HK$0.0900 55
Growth DCF
Growth DCF HK$0.1200 HK$0.1400 HK$0.1700 80
Rev-Margin DCF HK$0.1100 HK$0.1500 HK$0.1900 74
Economic Profit
Residual Income HK$0.0700 HK$0.0700 HK$0.0800 76
ROIC Compounder HK$0.0800 HK$0.0900 HK$0.1000 72
Growth Earnings
Growth-Adj P/E HK$0.1000 HK$0.1400 HK$0.1800 68

Open the full fair value analysis →

Quality Score breakdown

Overall quality 77/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 56
How much profit the company makes from its sales and capital
Quality Growth 86
Are margins and returns getting better?
Cashflow 52
Do the profits arrive as real cash?
Financial strength 97
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 61
How calm the share price moves, does not count
Price momentum 100
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 100
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+6.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.8%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
−26.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−32.2%
Dividend (yield on the price)5.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−12.6% vs −9.3%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 4%
2025 sits 334% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+10.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (figures in SGD, Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about +8.6% a year for the price.

1650 screens overvalued: fair value 33% below the price. Compare with Cintas Corporation →

Compare Hygieia Group Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 246 stocks

Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 77 · Top 25%
Fair Value upside −33.3% · Bottom 25%
Profitability
Return on equity (12 months) 6.8% · Below median
Return on assets 6.9% · Above median
Net margin (12 months) 2.2% · Below median
Operating margin (12 months) 0.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 7.3% · Above median
Dividend yield (12 months) 5.8% · Top 25%

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/E (12 months) 20.3× · Pricier than median
P/B 2.02× · Pricier than median
P/S (12 months) 0.64× · Cheaper than median
Price / free cash flow (fiscal year) 16.1× · Pricier than median
EV/EBITDA 64.8× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 41
FUTURE (revenue growth)37 · sector 34
PAST (return on equity)27 · sector 35
HEALTH (low debt)100 · sector 93
DIVIDEND (yield)100 · sector 56

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
RB Global, Inc RBA C$135.65 C$149.80 +10% vs 1650
Copart, Inc CPRT $31.83 $35.01 +10% vs 1650
Wolters Kluwer N.V WKL €90.84 €98.05 +8% vs 1650
Global Payments Inc GPN $91.90 $87.83 −4% vs 1650
Brambles Limited BXB A$22.20 A$19.45 −12% vs 1650
Cintas Corporation CTAS $226.24 $188.90 −17% vs 1650
Rentokil Initial plc RTO $23.91 $19.63 −18% vs 1650
Thomson Reuters Corporation TRI $109.30 $70.75 −35% vs 1650
Aramark ARMK $53.94 $23.04 −57% vs 1650
UL Solutions Inc ULS $80.36 $33.46 −58% vs 1650

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Hygieia Group Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Hygieia Group Limited Fair Value". https://www.fairvalue-calculator.com/stock/1650

Frequently asked questions

Is Hygieia Group Limited (1650) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of HK$0.1400 versus a price of HK$0.2100, about 33% lower (overvalued).
What is the fair value of 1650?
Our model-based fair value for Hygieia Group Limited is HK$0.1400 (as of Nov 14, 2026), built from audited fundamentals. The current price: HK$0.2100.
What is the quality score of 1650?
Hygieia Group Limited has a Quality Score of 77/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hygieia Group Limited (1650)?
Our model-based price target is the fair value of HK$0.1400 (as of Nov 14, 2026) from 25 valuation models. Cautious scenario HK$0.1200, optimistic scenario HK$0.1900. It is a calculation from audited fundamentals, not an analyst target.
What is the Hygieia Group Limited stock forecast for 2026?
Our models put fair value at HK$0.1400, about 33% lower versus a price of HK$0.2100 (overvalued). Cautious scenario HK$0.1200, optimistic scenario HK$0.1900. The calculation is refreshed regularly with new filings.
What is the revenue of Hygieia Group Limited (1650)?
Hygieia Group Limited reported trailing-twelve-month revenue of about 83.6M SGD (latest available figure, as of Nov 14, 2026).
Does Hygieia Group Limited pay a dividend?
Hygieia Group Limited currently shows a dividend yield of 5.80% relative to its recent price (as of Nov 14, 2026).
How much is the dividend of Hygieia Group Limited (1650) and when is the ex-dividend date?
Hygieia Group Limited pays a dividend of HK$0.0122 per share a year, a dividend yield of 5.8%. The last ex-dividend date was Sep 10, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 152% of earnings. Free cash flow covers the dividend 0.83 times. Our assessment: Pays more than it earns. The company pays out more in dividends than it earns, and free cash flow clearly does not cover the dividend either. It may need to be cut unless profits recover.
What growth is priced into Hygieia Group Limited (1650)?
For today's price to be fair in a discounted-cash-flow model, Hygieia Group Limited would have to grow free cash flow by 10.9 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 1.8 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 14, 2026.
What discount rate (WACC) does the fair value of 1650 use?
Our models discount Hygieia Group Limited at 11.8 %: a base by market capitalisation (micro), damped by beta 0.11, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Hygieia Group Limited that is +10.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Hygieia Group Limited (1650) delivered so far?
Over the past 5 years revenue at Hygieia Group Limited grew 1.8 % a year. The price currently implies free-cash-flow growth of +10.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Hygieia Group Limited (1650) growing?
The median revenue growth in the sector is +7.9 % a year. That is the yardstick for the growth priced into Hygieia Group Limited (+10.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Hygieia Group Limited (1650)?
The free-cash-flow yield on the price is 4.83 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Hygieia Group Limited produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Hygieia Group Limited (1650)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hygieia Group Limited it is HK$0.1400 per share (as of Nov 14, 2026), against a price of HK$0.2100. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Hygieia Group Limited stock overvalued or undervalued in 2026?
As of Nov 14, 2026, 1650 trades above its calculated fair value: price HK$0.2100, fair value HK$0.1400, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1650?
No. The price is what the market pays today (HK$0.2100); the fair value is what the company's own numbers justify (HK$0.1400). For Hygieia Group Limited the two are HK$0.0700 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hygieia Group Limited worth?
The market values Hygieia Group Limited at about HK$420M (market capitalisation, as of Nov 14, 2026). Per share that is HK$0.2100; our models calculate a fair value of HK$0.1400 per share.
What do the bullish and bearish scenarios say about 1650?
Our models span a range for Hygieia Group Limited: cautious scenario HK$0.1200, base HK$0.1400, optimistic HK$0.1900 per share (as of Nov 14, 2026, price HK$0.2100). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 1650?
Hygieia Group Limited trades at a price-to-earnings ratio of 20.3 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$0.1400 is built from several models across several years. Other multiples: P/B 2.0, P/S 0.6, EV/EBITDA 64.8.
How solid is the balance sheet of Hygieia Group Limited (1650)?
Balance-sheet figures for Hygieia Group Limited (as of Nov 14, 2026): return on equity 6.8%. They feed the Quality Score of 77/100, which measures business quality independently of the share price.
How far is 1650 from its 52-week high?
Hygieia Group Limited trades at HK$0.2100, at its 52-week high of HK$0.2100 and 155% above the low of HK$0.0825 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.1400 is for.
Which stocks are comparable to Hygieia Group Limited?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hygieia Group Limited stock attractive at the current price?
The data as of Nov 14, 2026: price HK$0.2100, calculated fair value HK$0.1400 (−33%), Quality Score 77/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 1650 calculated?
We run Hygieia Group Limited through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of HK$0.1400 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Hygieia Group Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hygieia Group Limited (1650)?
The closing price on Nov 13, 2026 was HK$0.2100. Our model-based fair value is HK$0.1400, about 33% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hygieia Group Limited right now?
A high-quality business (quality 77/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (HK$0.1900). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Hygieia Group Limited

How large is the market capitalisation of Hygieia Group Limited (1650)?
The market capitalisation of Hygieia Group Limited is HK$420M (≈ $53.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hygieia Group Limited (1650)?
The price-to-sales ratio of Hygieia Group Limited is 0.67 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Hygieia Group Limited (1650)?
The dividend yield of Hygieia Group Limited is 5.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hygieia Group Limited (1650)?
The net margin of Hygieia Group Limited is 3.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hygieia Group Limited (1650)?
The return on equity (ROE) of Hygieia Group Limited is 6.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hygieia Group Limited (1650)?
On an EBIT basis the return on assets of Hygieia Group Limited is 4.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hygieia Group Limited (1650)?
The operating margin of Hygieia Group Limited is 0.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hygieia Group Limited (1650)?
Revenue at Hygieia Group Limited is growing 7.3% versus a year earlier (3y avg +7.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hygieia Group Limited (1650)?
Earnings per share at Hygieia Group Limited are down 41.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Hygieia Group Limited (1650) hold?
Hygieia Group Limited holds more cash than debt, 7.9M SGD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Hygieia Group Limited in the live analysis

One click puts Hygieia Group Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.